Our Ongoing Commitment to Multiple Myeloma Patients

Globally, about 176K people were diagnosed with #MultipleMyeloma (MM) in 2021. Despite current treatment options, high relapse rates require innovative approaches.

We’re working to evolve research around #BCMA, a promising target in MM.

For more: https://www.mmwayforward.com/

#EBMT22